China International Capital Corporation Limited recently released an updated set of rules governing its Board of Directors’ authority and procedures. Under these revised guidelines, the Board comprises seven to fifteen members, including one employee director. Internal directors cannot exceed half the total number of directors, and the chairman is elected by a majority of Board members.
The Board holds at least four meetings annually and may convene additional sessions under specific circumstances. It oversees matters such as convening shareholders’ meetings, deciding on strategic business plans, formulating profit distribution proposals, reviewing major investments, and managing disclosure obligations. The term of office for each director is three years, with the possibility of re-election at the end of a term.
Several specialized committees operate under the Board, including the Strategy and ESG Committee, Remuneration Committee, Nomination and Corporate Governance Committee, Audit Committee, Risk Management Committee, and Related-Party Transaction Control Committee. Each committee is composed of directors chosen based on professional expertise and is tasked with key responsibilities, from setting development strategies to monitoring compliance, remuneration, and risk management.
The rules specify the procedures for scheduling Board meetings, issuing notices, providing meeting materials to all directors, and conducting votes. Extraordinary meetings can be called if proposed by a certain number of shareholders, directors, or relevant committees. A resolution is approved by a majority of the Board unless otherwise stipulated. Directors must attend meetings in person or by proxy; if a director is unable to participate, a written proxy may be granted to another director.
Meeting minutes serve as official records, detailing the proposals considered, voting results, and any dissenting opinions. These updated rules emphasize transparency, efficiency, and adherence to regulatory requirements, and are effective upon the shareholders’ meeting’s approval.